HomeNewsWorld'No evidence' that recovered COVID-19 patients cannot be reinfected: WHO

'No evidence' that recovered COVID-19 patients cannot be reinfected: WHO

In a scientific brief, the United Nations agency warned governments against issuing "immunity passports" or "risk-free certificates" to people who have been infected as their accuracy could not be guaranteed.

April 25, 2020 / 18:57 IST

The World Health Organisation (WHO) said on Saturday that there was currently "no evidence" that people who have recovered from COVID-19 and have antibodies are protected from a second coronavirus infection.

In a scientific brief, the United Nations agency warned governments against issuing "immunity passports" or "risk-free certificates" to people who have been infected as their accuracy could not be guaranteed.

The practice could actually increase the risks of continued spread as people who have recovered may ignore advice about taking standard precautions against the virus, it said.

"Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an 'immunity passport' or 'risk-free certificate' that would enable individuals to travel or to return to work assuming that they are protected against re-infection," the WHO said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection," it said.

Chile said last week it would begin handing out "health passports" to people deemed to have recovered from the illness. Once screened to determine if they have developed antibodies to make them immune to the virus, they could immediately rejoin the workforce.

The WHO said it continued to review the evidence on antibody responses to the virus, which emerged in the central Chinese city of Wuhan late last year. Some 2.8 million people have been reported to be infected by the novel coronavirus globally and 196,298 have died, according to a Reuters tally.

Most studies have shown that people who have recovered from infection have antibodies to the virus, the WHO said. However, some of them have very low levels of neutralizing antibodies in their blood, "suggesting that cellular immunity may also be critical for recovery", it added.

Follow our full coverage of the coronavirus pandemic here.

Reuters
first published: Apr 25, 2020 06:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347